Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q2 EPS of ($0.18), $0.11 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.